创伤人群中COVID-19感染患者气管造口术的指征与建议:文献综述
本文按2020年PRISMA指南进行文献综述,纳入12篇讨论成人COVID-19血清阳性患者气管造口方案的论文。研究显示气管造口后死亡率高,尤其在老年患者中,是否造口需多因素决定;血清阳性至造口及脱机的等待时间数据无定论。COVID-19传染性一般在第9–10天最高,早期高死亡率可能混杂造口相关死亡率;造口操作、维护具气溶胶生成性,需调整技术、设备与人员。作者建议仅对不再传播COVID-19的患者考虑造口,并严格安全防护。
要点
- 仅对不再具有传染性的COVID-19患者考虑气管造口,并严格注意安全防护。
- 气管造口后死亡率高,尤其老年患者;是否造口需多因素决定。
- COVID-19传染性一般在第9–10天最高,早期高死亡率可能混杂造口相关死亡率。
- 手术气管造口时文献建议减少电灼使用;经皮气管造口时应使用一次性支气管镜。
- 非紧急更换气管造口管仅在患者COVID-19检测转阴后进行。
适用人群与场景
- 成人COVID-19血清阳性患者,讨论气管造口指征、时机与操作。
处置流程与药物剂量
- 手术气管造口时,文献建议减少电灼使用。
- 经皮气管造口时,应使用一次性支气管镜。
- 非紧急更换气管造口管仅在患者COVID-19检测转阴后进行。
- 仅对不再具有传染性的COVID-19患者考虑气管造口,并严格注意安全防护。
红旗征与不能漏的情况
- 气管造口操作、维护具气溶胶生成性,需仔细考虑并调整技术、设备与人员。
研究设计与关键结果
- 文献综述按2020年PRISMA指南进行,纳入12篇讨论成人COVID-19血清阳性患者气管造口方案的论文。
- 研究显示气管造口后死亡率高,尤其在老年患者中。
- 血清阳性至气管造口及脱机的等待时间数据无定论。
- COVID-19传染性一般在第9–10天最高;COVID-19早期高死亡率可能混杂气管造口相关死亡率。
证据类型、等级与局限
- 证据类型:文献综述(按2020年PRISMA指南,纳入12篇论文)。
- 局限:因缺乏可用数据且随新数据出现可能变化,缺乏COVID-19血清阳性患者气管造口的完整指南,现有指南可能随疾病演变而更新。
对床旁实践的改变
- 作者认为,仅对不再具有传染性的COVID-19患者考虑气管造口,并严格注意安全防护。
- 作者认为,手术气管造口时减少电灼使用,经皮气管造口时使用一次性支气管镜。
- 作者认为,非紧急更换气管造口管仅在患者COVID-19检测转阴后进行。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
This review explores the current body of evidence pertaining to tracheostomy placement in COVID-19 seropositive patients and summarizes the research by tracheostomy indications, timing, and procedure. Literature review was performed in accordance with the 2020 PRISMA guidelines and includes 12 papers discussing protocols for adult patients seropositive for COVID-19. The studies demonstrated high mortality rates after tracheostomy, especially in geriatric patients, and suggested a multifactorial determination of whether to perform a tracheostomy. There was inconclusive data regarding wait time between testing seropositive, tracheostomy, and weaning off of ventilation. COVID-19 generally reaches highest infectivity between days 9 and 10; furthermore, high early mortality rates seen in COVID-19 may confound mortality implicated by tracheostomy placement. Due to the aerosol-generating nature of tracheostomy placement, management and maintenance, techniques, equipment, and personnel should be carefully considered and altered for COVID-19 patients. With surgical tracheostomy, literature suggested decreased usage of electrocautery; with percutaneous tracheostomy, single-use bronchoscope should be used. The nonemergent exchange of tracheostomy should be done only after the patient tested negative for COVID-19. Placement of tracheostomy should only be considered in COVID-19 patients who are no longer transmissible, with rigorous attention to safety precautions. Understanding procedures for airway maintenance in a respiratory disease like COVID-19 is imperative, especially due to current shortages in ventilators and PPE. However, because of a lack of available data and its likelihood of change as more data emerges, we lack complete guidelines for tracheostomy placement in COVID-19 seropositive patients, and those existing will likely evolve with the disease.
参考来源
- Barbera-Mirza J, Chan K, Newsome K, et al. Indications and Recommendations for Tracheostomy in Trauma Population With COVID-19 Infection: A Review of the Literature. Am Surg. 2021. PMID: 34743584. doi:10.1177/00031348211054711
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。